16 Patents
- US125656532026ATAXIN3 (ATXN3) Rnai Agent Compositions and Methods of Use Thereof
ALNYLAM PHARMACEUTICALS, Inc.
0 cites - US125347312026Alpha-2a Adrenergic Receptor (ADRA2A) Irna Agent Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - US124801252025Patatin-like Phospholipase Domain Containing 3 (PNPLA3) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - US124160062025Cell Death-inducing Dffa-like Effector B (CIDEB) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - US124045082025Ketohexokinase (KHK) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - 0 cites
- US123658962025Complement Component C3 Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - US122585652025Complement Component C3 Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - US120496302024Factor XII (F12) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - 0 cites
- 0 cites
- US119937742024Huntingtin (HTT) Irna Agent Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - US119651662024Complement Factor B (CFB) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - US119590812024Transthyretin (TTR) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - US119268322024Ketohexokinase (KHK) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - US116494592023Superoxide Dismutase 1 (SOD1) Irna Compositions and Methods of Use Thereof for Treating or Preventing Superoxide Dismutase 1-(SOD1-) Associated Neurodegenerative Diseases
Alnylam Pharmaceuticals, Inc.
0 cites